Brief: Two Cos Begin Due Diligence On Redwood Pharma's Rp501
May 7 (Reuters) - Redwood Pharma AB REDWPH.ST :
* TWO INTERNATIONAL COS BEGIN DUE DILIGENCE ON REDWOOD
PHARMA'S
PRODUCT RP501 AHEAD OF POTENTIAL COMMERCIAL AGREEMENTS
Source text for Eikon: ID:nWkr4dkGXY
Further company coverage: REDWPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Redwood Pharma AB
See all newsBrief: Redwood Pharma Says Files For Bankruptcy
Brief: Redwood Pharma Provides New Update Regarding Divestment Of Company Assets
Brief: Redwood Pharma Updates On Process For Divesting Assets
Brief: Redwood Pharma To Propose Liquidation At EGM
Brief: Redwood Pharma: Minimum Level In Rights Issue Not Reached